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Organ development is a complex process involving the coordination of cell proliferation, differentiation, and morphogenetic events. Using
a screen to identify genes that function coordinately with lin-35/Rb during animal development, we have isolated a weak loss-of-function
(LOF) mutation in pha-1. lin-35; pha-1 double mutants are defective at an early step in pharyngeal morphogenesis leading to an abnormal
pharyngeal architecture. pha-1 is also synthetically lethal with other class B synthetic multivulval (SynMuv) genes including the C. elegans
E2F homolog, efl-1. Reporter analyses indicate that pha-1 is broadly expressed during embryonic development and that its functions reside in
the cytoplasm. We also provide genetic and phenotypic evidence to support the model that PHA-1, a novel protein, and UBC-18, a ubiquitin-
conjugating enzyme that we have previously shown to function with lin-35 during pharyngeal development, act in parallel pathways to
regulate the activity of a common cellular target.
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Introduction ‘‘synthetic’’ phenotype. Although the full extent of geneticStudies over the past 30 years have revealed the tremen-
dous complexity in the genetic and biochemical mecha-
nisms that control organismal development. It is now
evident that in addition to being controlled by large numbers
of gene products, most developmental processes are regu-
lated by intricate networks of parallel and intersecting
pathways. This facet of developmental control is under-
scored by the widespread phenomenon of genetic redun-
dancy—the observation that two or more genes may
perform similar or complementary biological functions.
Because of such overlap, individual mutations in many
genes may have little or no effect on the developmental
program of the organism. In contrast, compound mutations
in two or more ‘‘redundant’’ genes may produce a clear-cut0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved
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yeast and C. elegans indicate that a substantial fraction of
genes (perhaps the majority) direct functions that are at least
partially, if not largely, redundant with the activities of other
genes (Fraser et al., 2000; Hodgkin, 2001; Kamath and
Ahringer, 2003; Smith et al., 1996; Tong et al., 2004;
Winzeler et al., 1999). This unavoidable aspect of biology
presents a continuing conceptual and technical challenge to
researchers seeking to understand the complex means by
which cellular and developmental processes are controlled.
One of the best-studied examples of genetic redundancy in
a multicellular organism is the synthetic multivulval (Syn-
Muv) mutants of C. elegans (Ferguson and Horvitz, 1989).
Most SynMuv genes belong exclusively to one of two
classes, A or B. In general, the isolated class A and B
mutations have little or no phenotype either as single mutants
or when paired with other mutations from the same class.
However, animals containing compound mutations in genes
from both classes display a highly penetrant Muv phenotype,
indicating that class A and B genes are genetically redundant
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functions of the class A genes are largely unknown, many
class B genes encode homologs of well-studied transcrip-
tional regulators. These include histone deacetylase (Lu and
Horvitz, 1998); several nucleosome remodeling (NURD)
components (Solari and Ahringer, 2000; von Zelewsky et
al., 2000); a heterochromatin protein 1 homolog, hpl-2
(Couteau et al., 2002); efl-1, a homolog of mammalian E2F
(Ceol and Horvitz, 2001); and the C. elegans Retinoblastoma
protein (Rb) homolog, lin-35 (Lu and Horvitz, 1998).
A large body of work, mostly from mammalian systems,
has generated a model in which Rb, when bound to E2F,
recruits factors that can mediate transcriptional repression
(reviewed by Harbour and Dean, 2000; Kaelin, 1999;
Morris and Dyson, 2001). These factors include histone
deacetylase (Brehm et al., 1998; Luo et al., 1998; Magna-
ghi-Jaulin et al., 1998), NURD complex components
(Dunaief et al., 1994; Strober et al., 1996; Zhang et al.,
2000), and proteins associated with heterochromatin forma-
tion and maintenance (Dahiya et al., 2001; Narita et al.,
2003; Nielsen et al., 2001). This leads to localized changes
in chromatin structure and the down-regulation of E2F
target genes, many of which include factors required for
the initiation and execution of S phase and DNA replication
(e.g., DeGregori et al., 1995; Dou et al., 1994).
Through screens for mutations that show synthetic phe-
notypes with lin-35, we have previously shown that fzr-1, a
conserved component of the APC ubiquitin–ligase complex,
functions redundantly with lin-35 to control cell cycle exit in
multiple postembryonic cell lineages of C. elegans (Fay et
al., 2002). More recently, we identified a role for lin-35 and a
ubiquitin-conjugating enzyme, ubc-18, in the development
of the anterior digestive tract (Fay et al., 2003). lin-35; ubc-
18 double mutants are defective at an early step in pharyn-
geal morphogenesis that involves a transformation in the
orientation of a subset of pharyngeal cell precursors. This
finding represents one of the first pieces of in vivo evidence
demonstrating a role for Rb family proteins in organ mor-
phogenesis and indicates that lin-35 may have developmen-
tal functions that are not connected to cell cycle control.
Other evidence to suggest a direct role for Rb family
members in tissue morphogenesis includes recent work by
Ruiz et al. (2003), demonstrating that the Rb-related proteins
p107 and p130 function in the formation of hair follicles and
incisors in mice. Consistent with this, microarray analyses
indicate that both Rb and E2F participate in the regulation of
a sizeable number of genes that are not connected to cell
cycle control, including factors involved in cell adhesion,
signal transduction, and pattern formation (Black et al.,
2003; Dimova et al., 2003; Ishida et al., 2001; Markey et
al., 2002; Muller et al., 2001; Russo et al., 2003; Vernell et
al., 2003; Wells et al., 2003). Moreover, altered expression of
E2F can disrupt embryonic patterning in both C. elegans and
Xenopus through mechanisms that appear to be independent
of cell cycle control (Page et al., 2001; Suzuki and Hemmati-
Brivanlou, 2000).Here, we report the identification of a synthetic genetic
interaction between lin-35 and mutations in the gene pha-1.
Interestingly, lin-35; pha-1 double mutants show defects in
pharyngeal development that appear largely identical to
those observed for lin-35; ubc-18 double mutants. More-
over, we present genetic data suggesting that all three genes
(lin-35, pha-1, and ubc-18) may function in parallel path-
ways to regulate a common molecular target.Materials and methods
Strains and genetic methods
Maintenance, culturing, and genetic manipulations of C.
elegans were carried out according to standard procedures at
16jC, 20jC, and 25jC, as indicated (Sulston and Hodgkin,
1988). Strains used in the phenotypic analysis include lin-
35(n745), WY119 [lin-35; pha-1(fd1); kuEx119], WY114
[pha-1(fd1)], WY128 [lin-35; vab-7(e1562), pha-1(e2123);
kuEx119], WY115 [lin-35; pha-1(fd1); pha-4::GFP;
kuEx119], WY116 [lin-35; pha-1(fd1); myo-2::GFP;
kuEx119], WY117 [lin-35; pha-1(fd1); ajm-1::GFP;
kuEx119], WY130 [vab-7(e1562), pha-1(e2123); myo-2::
GFP], WY131 [vab-7(e1562), pha-1(e2123); ajm-1::GFP],
WY132 [vab-7(e1562), pha-1(e2123); pha-4::GFP-mem],
MH1384 (ajm-1::GFP), SM469 (pha-4::GFP-NLS), SM481
(pha-4::GFP-mem), PD4792 (myo-2::GFP), DP132 (unc-
119::GFP), GE42 [vab-7, pha-1(e2123)], and GE24 [(pha-
1(e2123)]. The extrachromosomal array kuEx119 expresses
both wild-type lin-35 as well as a ubiquitously expressed
GFP reporter (sur-5::GFP; Fay et al., 2002).
To generate lin-35; pha-1(fd1)/pha-1(e2123) animals, we
used the following two approaches: WY125 [lin-35(n745);
pha-1(fd1), dpy-18(e364); kuEx119] animals were crossed to
lin-35 males and male cross-progeny were in turn mated to
WY128 hermaphrodites. Cross-progeny animals of the cor-
rect genotype were identified as wild-type-appearing GFP+
hermaphrodites that produced wild-type, Dpy, and Vab
progeny. We note that 42 of 43 F1 progeny that displayed
the correct genotype generated strains that were dependent
on the array (kuEx119) for viability. As an additional
approach, we crossed lin-35(n745)/+; pha-1(e2123), dpy-
18(e364) males to WY41 [lin-35(n745); vab-7(e1562), pha-
1(fd1); kuEx119] hermaphrodites and identified the correct
cross-progeny as wild-type GFP+ hermaphrodites that pro-
duced wild-type, Dpy, and Vab progeny and were dependent
on the array (kuEx119) for viability.
Strains used to map fd1 include WY64 [lin-35(n745);
vab-7(e1562), unc-71(e541)], WY94 [lin-35(n745); vab-
7(e1562), fd1; unc-71(e541); kuEx119], WY105 [lin-
35(n745) back-crossed to CB4856 five times], and
MH1797 [lin-35(n745); unc-32(e189), vab-7(1562)]. For
three-point mapping with WY64, 26 of 29 Unc-non-Vab
recombinants acquired the mutant fd1 allele. SNP mapping
was carried out using WY94 and WY105 to isolate Unc-
D.S. Fay et al. / Developmental Biology 271 (2004) 11–25 13non-Vab recombinants of genotypes lin-35; fd1, unc-71;
kuEx119 and lin-35; unc-71. fd1 was initially mapped to
the left of SNP eam62b02.s1@278,a,62; eam62b02.s1
@278,a,62; and yy48e02.s1@180,a,62; and to the right
of SNP yy44f01.s1@168,g,59. Through sequencing of the
CB4856 strain, we identified additional SNPs to place fd1
to the right of the following polymorphism: a 10-bp
insertion (CTAAAAAAAT) in CB4856 between nucleoti-
des 25,625/25,626 of sequencing contig Y48A6C. fd1 was
also placed to the left of the following polymorphisms in
sequencing contig Y47D3A: G!T at position 35,344;
C!T at 34,250; C!A at position 34,238; G!A at
32,935; and T!C at 32,854. This last polymorphism,
along with the insertion at 25,625 of Y48A6C, formally
defined the SNP mapping endpoints for fd1. This region
spans 42,865 bp and contains five predicted open reading
frames.
To test suppression of lin-35; ubc-18 by sup-36 and sup-
37, dpy-13, unc-24/+ and dpy-11, unc-76/+ males were
crossed into lin-35; ubc-18, unc-32; kuEx119 hermaphro-
dites and cross-progeny males were further crossed to sup-
36 and sup-37 hermaphrodites, respectively, to generate lin-
35/+; ubc-18, unc-32/+; sup-36/dpy-13, unc-24 and lin-35/
+; ubc-18, unc-32/+; sup-37/dpy-11, unc-76 hermaphro-
dites. Putative lin-35; ubc-18, unc-32; sup-36 and lin-35;
ubc-18, unc-32; sup-37 animals were subsequently identi-
fied as Unc (unc-32) animals that failed to segregate Dpy
Unc progeny (dpy-13, unc-24 or dpy-11, unc-76) and
expressed a Muv phenotype when placed on lin-15a(RNAi)
plates (indicating that lin-35 was homozygous). Finally,
candidate strains were sequenced by PCR amplification to
verify the presence of the homozygous ubc-18(ku354)
molecular lesion (Fay et al., 2003).
Other methods
pha-1 rescue
Rescue of lin-35; pha-1(fd1) synthetic lethality was
obtained by injecting a mixture of plasmid pBX (Granato
et al., 1994a,b), which contains the wild-type pha-1 gene,
and pRF4, which encodes a dominant roller gene (Mello and
Fire, 1995), into WY119. Multiple non-GFP-expressing
roller animals that no longer required the kuEx119 array
(containing lin-35-rescuing sequences) for viability were
then identified in subsequent generations.
RNAi
RNAi was carried out according to standard methods
(Fire et al., 1998; Fraser et al., 2000). Feeding vectors were
constructed as previously described (Fay et al., 2002, 2003).
For pha-1 RNAi, a fragment spanning nucleotides 759–
1424 of the pha-1 cDNA was subcloned into the polylinker
of pPD129.36. RNAi inactivation of pha-1 (by feeding
methods) substantially reduced, but did not abolish expres-sion of the pha-1::GFP reporter, indicating that reduction of
pha-1 activity by this method is incomplete.
GFP reporter constructs
To express a functional PHA-1::GFP fusion protein, a
genomic sequence containing approximately 2.9 kb of pha-
1 upstream regulatory sequences (from nucleotide position
28,395 of Y48A6C to the pha-1 start codon at position
31,284) along with the pha-1 genomic coding region (minus
the C-terminal 8 aa) was fused in frame to GFP (at the C
terminus of PHA-1). This construct (40 ng/Al) was injected
into N2 animals along with pRF4 (100 ng/Al) and herring
sperm DNA (30 ng/Al; as a carrier) to generate strains
carrying stable extrachromosomal arrays. This expressed
fusion construct was determined to be functional based on
its ability to suppress the lethality of pha-1(e2123) mutants
(at 25jC). Similar expression patterns were also observed
using reporter constructs containing approximately 2.9 kb of
upstream regulatory sequences together with genomic
sequences encoding the first 137 aa of PHA-1 fused to a
GFP containing a nuclear localization signal.
Computational analyses
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lin-35; fd1 double mutants are defective at pharyngeal
development
In screens for mutations that show synthetic phenotypes
with lin-35/Rb loss of function (LOF), we identified a single
mutation (fd1) defining a genetic locus on the right arm of
chromosome III (for details on screening methods, see Fay
et al., 2002). Most lin-35; fd1 double mutants arrested in
early larval development, although a small percentage
gradually matured into small sterile adults [Figs. 1A, B;
Table 1; see lin-35; pha-1(fd1)]. Mutant adults frequently
Fig. 1. Synthetic genetic interactions between lin-35 and pha-1. DIC (A, C, E, F, G) and corresponding GFP fluorescence (B, D) images. (A) The large adult
(black arrowhead) with GFP fluorescence is of genotype lin-35; pha-1(fd1); kuEx119. The small, growth-retarded adults (white arrowheads) and arrested larva
(white arrow) are of genotype lin-35; pha-1(fd1). Inset in A and B shows an arrested L1 larva (black arrow) of genotype lin-35; pha-1(fd1); kuEx119 that was
treated with lin-35(RNAi). (C, D) Wild-type, (E) lin-35; pha-1(fd1), and (F) pha-1(e2123) (at 25jC) L1 larvae expressing myo-2::GFP (insets E, F), which
serves as a marker for pharyngeal muscle cell differentiation. Black and white arrowheads, posterior and anterior pharyngeal boundaries, respectively; black
arrows, the pharyngeal lumen. Note the abnormal shape but clear expression of the myo-2::GFP reporter in the lin-35; pha-1(fd1) and pha-1(e2123) larvae. (G)
Representative pha-1(e2123) (at 25jC) terminally arrested embryos showing morphogenetic defects in the pharynx as well as overall body plan. Black arrows
indicate pharyngeal lumens. Note that the embryo in the upper right appears to have a ‘fully’ extended pharynx (arrowheads), but still shows strong defects in
body morphogenesis, indicating that gross morphogenetic defects are not a secondary consequence of failed pharyngeal extension. Scale bars: A, 100 Am for A,
B; C, 10 Am for C–F; G, 10 Am for G.
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defective mutants (Avery, 1993). An examination of larval-
arrested lin-35; fd1 mutants revealed that approximately
25% showed pharyngeal defects that were very similar to
what had been observed for lin-35; ubc-18 mutants (Figs.
1E, F; Table 1; Fay et al., 2003). The pharynges in these
animals were markedly shortened as compared with wildtype (Figs. 1C, D) and did not form a functional connection
to the mouth or buccal cavity (termed the Pun phenotype,
for pharynx unattached). Upon hatching, such animals
starved because of an inability to feed. Other larval-arrested
double mutants showed more subtle defects such as irreg-
ular or indistinct pharyngeal contours (data not shown),
which probably result in pharyngeal malfunction.
Table 1
Genetic interactions between lin-35 and pha-1
% Larval arresta % Pun % Sterile Average brood size
N2 <1 (many) 0 (n = 260) <1 (many) 264 (F18) (n = 50)b
lin-35(n745) 1 (n = 268) 0 (n = 268) 4 (n = 100)b 98 (F43) (n = 10)b
pha-1(fd1) 9 (n = 504) 0 (n = 131) 0 (n = 30) 216 (F19) (n = 12)
pha-1(e2123) (16jC) 0 (n = 189) 0 (n = 189) ND ND
lin-35; pha-1(fd1)c 93 (n = 91) 23 (n = 199) 100 (n = 20) ND
lin-35; pha-1(e2123) (16jC)c 100 (n = 148) 78 (n = 79) ND ND
lin-35; pha-1(e2123)/pha-1(fd1) (16jC)c,d 89 (n = 106) 12 (n = 92)e 90 (n = 30) 6 (n = 3)
lin-35; pha-1(fd1)/+f 0 (n = 113) 0 (n = 113) 60 (n = 20) 49 (F51) (n = 8)
lin-35; pha-1(e2123)/+ (25jC)f 0 (n = 105) 0 (n = 105) 60 (n = 20) 36 (F40) (n = 8)
N2 pha-1(RNAi) ND 0 (n = 129) 0 (n = 20) ND
lin-35; pha-1(RNAi) ND 4 (n = 207) 100 (n = 20) ND
lin-35; pha-1(fd1); pha-1(RNAi) ND 73 (n = 37) ND ND
N2 lin-35(RNAi) ND 0 (n = 163) ND ND
pha-1(fd1); lin-35(RNAi) 76 (n = 177) 5 (n = 320) 97 (n = 30) ND
pha-1(e2123); lin-35(RNAi) (16jC) 92 (n = 122) 75 (n = 63) ND ND
All experiments were conducted at 20jC unless otherwise indicated.
a Animals either died as larvae or failed to reach maturity after 5 days.
b Fay et al. (2002).
c Double-mutant animals were derived from the self-progeny of lin-35; pha-1; kuEx119 hermaphrodites. Progeny that failed to segregate the array (kuEx119)
were identified by their lack of GFP expression.
d For details on the construction of this strain, see Materials and methods.
e Non-Vab, non-Dpy larvae, derived from lin-35; pha-1(fd1), dpy-18/vab-7, pha-1(e2123) parents, were scored for the Pun phenotype.
f Heterozygous animals were obtained by mating lin-35 males to lin-35; vab-7, pha-1; kuEx119 hermaphrodites and scoring the effects in the non-Vab
kuEx119 progeny.
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were largely healthy with normal pharynges and brood
sizes that were similar to those of wild type (Table 1).
We did, however, observe a low incidence of larval
lethality in fd1 single mutants (Table 1). These larvae had
normal-appearing pharynges but arrested with a ‘‘fluid-
filled’’ morphology that has been reported for many
mutants, including hypomorhic alleles of genes comprising
the Ras/MapK signaling pathway (Han and Sternberg,
1990; Yochem et al., 1997). This phenotype has been
associated with defects in the excretory system, which
functions in C. elegans osmoregulation (Nelson and Riddle,
1984). We note that this class of larval-arrested animals was
not enhanced by the absence of lin-35 function (data not
shown) and could theoretically be due to a secondary
mutation in a closely linked gene.
fd1 defines a partial loss-of-function mutation in pha-1
fd1 was genetically mapped using a combination of
visible markers and single-nucleotide polymorphisms
(SNPs) to an approximately 43-kb genomic region con-
taining five predicted open reading frames (for details, see
Materials and methods). Because cosmid-based genomic
clones for use in transgenic rescue experiments were
unavailable for this region, we took a reverse-genetics
approach by testing the five candidate genes for synthetic
lethality with lin-35 using RNA-interference (RNAi). Only
one of the five genes in this region, Y48A6C.5, showed a
genetic interaction with lin-35 by RNAi. Interestingly, this
clone corresponds to pha-1, a gene previously implicatedin pharyngeal development (also see below). Although
pha-1(RNAi) (by feeding methods) had no effect on
wild-type animals (Gonczy et al., 2000; Kamath and
Ahringer, 2003; and this study), presumably due to the
inefficiency of the technique (also see methods), identical-
ly treated lin-35 mutant animals either arrested as small
larvae or progressed to become sterile adults (Table 1 and
data not shown). Importantly, a low, but significant,
percentage of arrested larvae showed pharyngeal defects
including the Pun phenotype (Table 1). As further evidence
that fd1 defines an allele of pha-1, we were able to rescue
the synthetic lethality of lin-35; fd1 double mutants
through the expression of wild-type pha-1 from an extra-
chromosomal array (see Materials and methods). Based on
the above findings, as well as additional results presented
below, we conclude that fd1 represents a weak LOF
mutation in pha-1.
To further examine the nature of the fd1 allele, we
reduced pha-1 activity in lin-35; pha-1(fd1) double mutants
through RNAi. As would be expected for a partial LOF
mutation, RNAi of pha-1 increased the severity of the
phenotype beyond that of the untreated double-mutant strain
(Table 1). In addition, we generated strains that were
homozygous for lin-35 but heterozygous for the pha-
1(fd1) mutation. Although these animals did not display a
Pun phenotype or arrest as larvae, we did observe an
increase in sterility and a reduction in brood size, as
compared with lin-35 mutants alone (Table 1). This is likely
attributable to a haploinsufficiency effect, a phenomenon we
had also observed in lin-35; ubc-18/+ mutant animals (Fay
et al., 2003).
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coding region of pha-1 in the fd1 mutant background.
Surprisingly, we failed to detect any differences from the
established wild-type pha-1 sequence, including the con-
served splice-junction sites. To see if a regulatory element
had been altered, we sequenced >3 kb upstream of the pha-1
transcriptional start site, as well as the four introns and 3V
UTR of the gene. Through this analysis, we identified a
single lesion (C!T) occurring 156 bp upstream of the pha-
1 start methione. This mutation was detected in six separate
pooled-PCR reactions of lin-35; pha-1(fd1) and pha-(fd1)
mutants, but was not present in the starting strain used to
isolate the fd1 mutation, lin-35; kuEx119 (MH1461). The
altered site [TATCC(C/T)TCCAG] does not correspond to
consensus sequences for any known transcription factors
(for details on the analysis tools used, see Materials and
methods). Given the location of this mutation, a straight-
forward explanation is that the mutated site leads to a
reduction in levels or delayed expression of the pha-1
transcript. We note that the region covered by our sequenc-
ing analysis extends several hundred base pairs past the
known poly-A signal of pha-1 and includes >1 kb of
upstream sequences that were previously shown to be
unnecessary for complete rescue of the pha-1 null pheno-
type (Granato et al., 1994a). Therefore, it is very unlikely
that we have failed to identify any relevant mutations in a
more distal regulatory element.
Previous work by Granato et al. (1994a) and Schnabel
and Schnabel (1990) identified multiple mutations in pha-1,
including the temperature-sensitive allele e2123. e2123
leads to a strong LOF phenotype in pha-1 (at the nonper-
missive temperature of 25jC) and encodes an altered
peptide containing a cysteine to tyrosine substitution at
amino acid position 169. pha-1(e2123) mutants raised atTable 2
Genetic interactions between pha-1 and ubc-18
% Larval arresta
ubc-18(ku354)b 3 (n = 223)
ubc-18; pha-1(RNAi) ND
lin-35; ubc-18b 84 (n = 192)
lin-35; ubc-18; pha-1(RNAi) ND
N2 ubc-18(RNAi)b 0 (n = 100)
pha-1(fd1); ubc-18(RNAi) ND
pha-1(e2123); ubc-18(RNAi) (16jC) ND
lin-35; ubc-18(RNAi)b 5 (n = 110)
lin-35; pha-1(fd1); ubc-18(RNAi) ND
lin-35; ubc-18; ubc-18(RNAi)b 91 (n = 140)
lin-35; ubc-18(ku354)/pha-1(e2123) (16jC)c ND
All experiments were conducted at 20jC, unless otherwise indicated.
a Animals either died as larvae or failed to reach maturity after 5 days.
b Fay et al. (2003).
c Animals of this genotype were generated by crossing lin-35; ubc-18, unc-32/+ ma
of the correct genotype were identified by the presence of Unc and Vab progeny
d Non-Vab animals, derived from lin-35; ubc-18, unc-32/vab-7, pha-1(e2123) pare
2/3 of the non-Vab larvae should be of genotype lin-35; ubc-18, unc-32/vab-7, ph
absence of any Pun larvae is not unexpected, given that the percentage of lin-35; u
the Pun phenotype would be further diminished by the maternal rescue of ubc-1825jC arrest almost uniformly as embryos that contain
abnormal (Pun) pharynges. In addition, these embryos often
show defects in overall body morphogenesis, suggesting
that pha-1 may function in the development of other tissues
(Fig. 1G; Schnabel and Schnabel, 1990). No obvious defects
are visible in pha-1(e2123) mutants propagated at the
permissive temperature of 16jC (Table 1; Schnabel and
Schnabel, 1990). However, we found that pha-1(e2123)
mutants grown at 16jC showed a strong synthetic pheno-
type with loss of lin-35 function (either through mutation or
RNAi; Table 1). Based on the percentages of Pun animals,
the phenotype of lin-35; pha-1(e2123) mutants (at 16jC)
appears to be more severe than that of lin-35; pha-1(fd1)
animals at all temperatures (Table 1 and data not shown).
Thus, the fd1 allele of pha-1 probably possesses more
residual activity than the e2123 allele at its permissive
temperature of 16jC.
We found that strains heterozygous for both the e2123
and fd1 alleles of pha-1 [pha-1(e2123)/pha-1(fd1)] were
viable at all temperatures, consistent with fd1 encoding a
weak LOF mutation. We also used a variety of methods to
generate lin-35; pha-1(e2123)/pha-1(fd1) animals (see
Materials and methods) to assess the ability of these alleles
to complement one another in the lin-35 mutant back-
ground. As expected, lin-35; pha-1(e2123)/pha-1(fd1)
mutants were nonviable and arrested primarily as larvae
(Table 1). As a control, lin-35; ubc-18(ku354)/pha-1(e2123)
animals were found to be uniformly viable (Table 2). These
results further confirm that fd1 is an allele of pha-1.
Somewhat surprisingly, however, lin-35; pha-1(e2123)/
pha(fd1) mutants showed a less severe phenotype (at both
16jC and 25jC) than either of the homozygous lin-35; pha-
1(fd1) or lin-35; pha-1(e2123) (at 16jC) strains, based on
the percentage of Pun larvae (Table 1 and data not shown).% Pun % Sterile Average brood size
0 (n = 101) 3 (n = 30) 9 (F28) (n = 14)
27 (n = 64) ND ND
4 (n = 192) 72 (n = 30) 3 (F2) (n = 7)
65 (n = 31) ND ND
0 (n = 100) 0 (n = 30) 221 (F23) (n = 8)
0 (n = 285) ND ND
77 (n = 62) ND ND
0 (n = 255) 23 (n = 30) 55 (F34) (n = 10)
66 (n = 111) ND ND
40 (n = 174) 77 (n = 30) 2 (F2) (n = 7)
0 (n = 167)d 5 (n = 20) ND
les to lin-35; vab-7, pha-1(e2123); kuEx119 hermaphrodites. Cross-progeny
in the next generation as well as by the absence of GFP expression.
nts, were scored for the Pun phenotype as L1 larvae. Based on percentages,
a-1(e2123) whereas 1/3 should be of genotype lin-35; ubc-18, unc-32. The
bc-18 Pun animals is normally very low (see Table 2) and that expression of
(Fay et al., 2003).
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PHA-1 protein may function in vivo as a homodimer. Thus,
in the mixed lin-35; pha-1(e2123)/pha-1(fd1) background,
low levels of wild-type PHA-1 protein, generated by the fd1
allele, may be able form functional dimers with the more
abundant e2123 PHA-1 protein product. This could lead to
higher overall levels of PHA-1 dimer activity in the mixed
allele strain than in homozygous lin-35; pha-1(fd1) or lin-
35; pha-1(e2123) mutants.
lin-35; pha-1 mutants are defective at an early step in
pharyngeal morphogenesis
To determine the underlying cause for the Pun pheno-
type, we analyzed three aspects of pharyngeal development
in lin-35; pha-1 double mutants: (1) the generation of
pharyngeal precursor cells, (2) the ability of precursor cells
to undergo terminal differentiation into multiple cell types,
and (3) the morphogenetic events required to form the
mature organ. Conceivably, defects in any of these process-
es could contribute to the observed phenotypes.
Specification of pharyngeal precursor cells is first initi-
ated during the mid-proliferative phase of embryogenesis,
approximately 150 min into development (Horner et al.,
1998; Sulston et al., 1983). To detect pharyngeal precursor
cells, we utilized a marker (pha-4::GFP) that is expressed in
all cells destined to form the pharynx, as well as other cells
comprising the digestive tract (e.g., intestinal, rectal, and
arcade cells of the buccal cavity; Horner et al., 1998). More
specifically, we counted pha-4::GFP+ cells in the head
region of mutant and wild-type embryos at the 1.5-fold
stage of embryogenesis, at which time pharyngeal elonga-
tion has been initiated in wild-type animals (Figs. 2A, B).
Importantly, we scored only double-mutant embryos that
had clearly failed to undergo pharyngeal elongation by this
stage (Figs. 2C, D). We also note that based on the size,
shape, and characteristic positions of intestinal cell nuclei,
we were able to unambiguously exclude these cells from our
counts.
lin-35; pha-1(fd1) double mutants showed a slight
reduction in the average number of cells expressing the
marker (95 F 8; n = 9; range, 80–105) as compared with
wild-type animals at this stage (100 F 3; n = 11; range,
95–104; Figs. 2A–D; Fay et al., 2003). Of the nine
mutant embryos analyzed, however, six contained 95 or
more cells. This indicates that a large proportion (perhaps
the majority) of mutant embryos contain indistinguishable
numbers of pharyngeal cell precursors from wild type.
Similar results were also observed in wild-type and lin-35;
pha-1(fd1) mutant Pun larvae (Figs. 2E–H). Thus, differ-
ences in the number of pharyngeal precursor cells cannot
account for the observed defects in our double mutants.
We note that these results are nearly identical with our
findings for lin-35; ubc-18 double mutants (Fay et al.,
2003). Furthermore, our results are consistent with earlier
analyses of pha-1 mutants, which detected no differencesin numbers of pharyngeal precursor cells in wild-type and
pha-1(e2123) mutants at 25jC (Schnabel and Schnabel,
1990).
The Pun pharynges of lin-35; pha-1(fd1) double
mutants, although abnormally shaped, displayed several
characteristics that are consistent with normal tissue
differentiation. These include the presence of a distinct
pharyngeal lumen, suggesting the differentiation of epi-
thelial cells (Figs. 1E, F). In addition, we have observed
sustained rhythmic pumping, a property of the pharynx in
wild-type animals, in many lin-35; pha-1(fd1) Pun larvae.
This finding indicates the presence of functional muscle
cells and may suggest some degree of proper neuronal
connectivity. In further support of these results, we have
observed strong expression of several GFP markers,
indicating the presence of differentiated muscle (myo-
2::GFP; Okkema et al., 1993), epithelium (ajm-1::GFP;
Mohler et al., 1998), and neurons (unc-119::GFP; Maduro
and Pilgrim, 1995) in the pharynges of lin-35; pha-1(fd1)
Pun mutants (Figs. 1E, F and data not shown). We also
note that we found no evidence indicating that the
morphogenesis defects are the direct result of a delay
in the timing of pharyngeal cell differentiation (data not
shown). From these data, we conclude that the terminal
differentiation of three pharyngeal cell types occurs in
lin-35; pha-1(fd1) double mutants. However, based on
our method of analysis, we cannot know that all cells
within the classes examined underwent correct terminal
differentiation.
We have previously shown that lin-35; ubc-18 mutants
are defective at an early step in pharyngeal morphogenesis
(Fay et al., 2003), termed ‘‘reorientation’’ (Portereiko and
Mango, 2001). At this time, a set of radially oriented
anterior pharyngeal precursor cells undergoes a shift in their
apical–basal polarity, such that their long axes become
aligned with the dorsal ventral axis of the embryo (Fig.
3M). Using a membrane-localized GFP reporter that is
expressed under the control of the pha-4 promoter, we were
able to follow this process in the double-mutant back-
ground. For technical reasons, these experiments were
carried out using the e2123 allele of pha-1 (at 16jC) in
combination with lin-35(RNAi). Our findings indicate that,
like lin-35; ubc-18 mutants, the majority (11/16) of lin-35;
pha-1 mutants examined were at least partially defective at
the reorientation step of pharyngeal morphogenesis (Figs.
3A–J). Interestingly, we found that pha-1(e2123) single-
mutant embryos grown at 25jC were not defective at early
stages of pharyngeal morphogenesis. Rather, these embryos
underwent pharyngeal elongation in an apparently normal
manner to form a transient attachment to the buccal cavity (n
> 100; Figs. 3K, L). At some later stage, this connection is
disrupted, leading to the Pun phenotype in pha-1(e2123)
mutants (Schnabel and Schnabel, 1990; and data not
shown). These results indicate that pha-1 has both indepen-
dent and overlapping functions with lin-35 during pharyn-
geal development, and that early pharyngeal morphogenesis
Fig. 2. pha-4::GFP expression in wild-type and lin-35; pha-1 mutant animals. DIC (A, C, E, G) and corresponding pha-4:GFP fluorescence (B, D, F, H)
images. (A–D) Approximately 1.5-fold-stage wild-type (A, B) and lin-35; pha-1(fd1) (C, D) embryos. Anterior is towards left and ventral is downwards.
Arrows indicate the pharyngeal boundaries. Note the difference in pharyngeal shape between wild-type and lin-35; pha-1(fd1) embryos. For embryos in A and
C, we detected 98 and 96 pha-4::GFP-expressing cells in the head region, respectively. The white bracket (D) demarcates several GFP-expressing arcade cells
that have failed to integrate with the pharynx. Also showing strong GFP expression in both embryos are the round intestinal cell nuclei in the posterior region of
the embryo. (E, F) Wild-type and (G, H) lin-35; pha-1(fd1) mutant (Pun) L1 larvae. Black and white arrowheads indicate the posterior and anterior pharyngeal
boundaries. The white brackets in H indicate nonintegrated arcade cells. Scale bars: in A, 10 Am for A–D; E, 10 Am for E–H.
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these gene products.
Differentiation in pha-1(e2123) mutants
Strong LOF mutations in pha-1 were previously reported
to interfere with the differentiation of multiple pharyngeal
cell types (Granato et al., 1994a; Okkema et al., 1997;
Schnabel and Schnabel, 1990). Three of the cell types
examined (muscle, gland, and marginal cells) failed to
express terminal differentiation markers based on antibody
staining, and a fourth cell type (epithelium) was inferred tobe affected based on the absence (or grossly delayed
appearance) of a pharyngeal lumen. Although these findings
differed significantly from our own observations of lin-35;
pha-1(fd1) double mutants, it was possible that our weak
LOF allele of pha-1 (fd1), in combination with lin-35 LOF,
was producing a qualitatively different phenotype than
strong LOF mutations in pha-1. Several observations, how-
ever, suggest that cell-type-specific differentiation may
occur in pha-1(e2123) mutants to a greater extent than
was previously thought. First, we observed a distinct pha-
ryngeal lumen in 98% (n = 110) of newly hatched pha-
1(e2123) larvae (at 25jC; as well as most late-stage embry-
Fig. 3. Early pharyngeal morphogenesis in wild-type and mutant embryos. DIC (A, C, E, G, I, K) and corresponding fluorescence (B, D, F, H, J, L) images
highlighting the shapes of pharyngeal cells. Black arrows, pharyngeal boundaries; white arrowheads, cells that have not undergone reorientation; white arrows,
cells having completed or initiated reorientation. (A, B) Awild-type lima-bean-stage embryo before pharyngeal morphogenesis has initiated. Note the radially
symmetric wedge-shaped leading-edge cells (arrowheads). (C, D) Awild-type 1.5-fold-stage embryo with early morphogenetic events completed. Note the shift
in polarity of the leading-edge cells. (E–J) pha-1(e2123); lin-35(RNAi) 1.5- to 2-fold-stage embryos (at 16jC). Note the lack of pharyngeal extension and the
presence of multiple leading-edge cells that have failed to undergo reorientation. (K, L) pha-1(e2123) single mutants at 25jC. Pharyngeal morphogenesis is
apparently normal under these conditions. (M) Cell shape changes that normally occur during the reorientation step of pharyngeal morphogenesis. For further
details, see text. Scale bars: in A, 10 Am for A, C, E, G, I, K; in B, 10 Am for B, D, F, H, J, L.
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robust expression of the ajm-1:GFP epithelial marker be-
ginning at the comma stage of embryogenesis and persisting
into adulthood (data not shown). Third, expression of the
myo-2::GFP reporter was observed in nearly all (99%; n =
64) pha-1(e2123) mutants (at 25jC), beginning at about the
3-fold stage of embyrogenesis (Figs. 1G, H and data not
shown). Although the intensity of GFP staining in pha-
1(e2123) mutants was somewhat reduced as compared with
wild type, the onset of expression appeared to be identical.
This result was surprising, as pha-1(e2123) mutants were
initially reported to not express the protein product of myo-2
(Granato et al., 1994a; Schnabel and Schnabel, 1990), based
on staining patterns with MYO-2-specific monoclonal anti-
bodies (Miller et al., 1983, 1986). It is possible, however,
that some of these differences may be attributable to an
increase in the sensitivity of our GFP reporter (myo-2::GFP)
vs. antibody staining. In addition, it remains possible thatPHA-1 acts posttranscriptionally to promote the translation
of myo-2 mRNA, thereby accounting for the discrepancy
between myo-2 mRNA and protein levels.
pha-1 is widely expressed and is concentrated in the
cytoplasm
To examine the expression pattern of pha-1 during
development, we generated strains that express a functional
‘‘full-length’’ PHA-1::GFP fusion protein under the regu-
latory control of the wild-type pha-1 promoter (for details,
see Materials and methods). Expression of the pha-1
reporter was first detected at the approximately 100-cell
stage in all somatic cells of the embryo (Figs. 4A, B). This
pattern of widespread expression continued through later
stages of embryonic development (Figs. 4C, D), diminish-
ing somewhat in intensity by the time of hatching. Expres-
sion was also observed in early-larval-stage animals (Figs.
Fig. 4. Expression of pha-1:GFP. DIC (A, C, E, G) and corresponding fluorescence (B, D, F, H) images of a functional PHA-1::GFP fusion protein expressed
under the control of the pha-1 promoter. Note expression in essentially all cells at the approximately 100-cell (A, B) and late-comma (C, D) stages of
embryonic development. Corresponding black and white arrows in panels A and B show the location of two nuclei. Note the lower level of nuclear vs.
cytoplasmic expression. Black arrows in panel C indicate the pharyngeal borders. (E, F) Expression in the head region of an L2 larva. Corresponding black and
white arrows, a GFP-expressing posterior pharyngeal muscle cell; black and white arrowheads, an anterior intestinal valve cell. (G, H) Expression in the tail of
an L1 larva. Black and white arrows, GFP-expressing neuronal cells; black and white arrowheads, intestinal cells. Note that at all stages, expression is
predominantly, if not exclusively, cytoplasmic. Scale bars: in A, 10 Am for A–D; in E, 10 Am for E–H.
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adults (data not shown). Strikingly, most if not all PHA-
1::GFP fusion protein localized to the cytoplasm (Fig. 4).
This was particularly apparent in larvae, where the contri-
bution of nonspecific GFP fluorescence coming from layers
outside of the central focal plane was minimized. In
addition, we saw no evidence for any dynamic regulation
of PHA-1 with respect to its subcellular localization.
Although these findings do not rule out the possibility that
some PHA-1 protein may normally be present in nuclei,
they strongly suggest that PHA-1 resides primarily, if not
exclusively, in the cytoplasmic compartment. Moreover,although it was possible that the tagged fusion protein
may have been mislocalized, either due to the presence of
the C-terminal GFP extension, or simply through over-
expression, the ability of the fusion protein to substitute
functionally for wild-type PHA-1 suggests that it is local-
izing to the correct cellular compartment. We note that a
previous report examining the expression pattern of pha-1
using a (nonfunctional) pha-1::lacZ reporter detected tran-
sient expression in only pharyngeal precursor and body
wall muscle cells (Granato et al., 1994a). Given that the
regulatory regions used in these two reporter constructs
were similar, these discrepancies may be attributable to
Table 3
Genetic interactions with SynMuv genes
% Puna
N2 (wild type) 0 (many)
pha-1(e2123)b 0 (n = 189)
lin-35(RNAi)c,d 0 (n = 50)
pha-1(fd1); lin-35(RNAi)d 5 (n = 320)
pha-1(e2123); lin-35(RNAi)b 75 (n = 63)
lin-37(RNAi)c,d 0 (n = 62)
pha-1(e2123); lin-37(RNAi)b 42 (n = 104)
lin-36(RNAi)c,d 0 (n = 58)
pha-1(e2123); lin-36(RNAi)b 4 (n = 162)
hda-1(RNAi)c,d,e 1 (n = 60)
pha-1(e2123); hda-1(RNAi)b 13 (n = 67)
let-418(RNAi)c,d,e 1 (n = 313)
pha-1(e2123); let-418(RNAi)b 4 (n = 152)
lin-53(RNAi)c,d,e 0 (n = 73)
pha-1(e2123); lin-53(RNAi)b 50 (n = 6)
efl-1(RNAi)c,d 0 (n = 50)
pha-1(e2123); efl-1(RNAi)b 20 (n = 88)
lin-15a(RNAi)c,d 0 (n = 54)
pha-1(e2123); lin-15a(RNAi)b 0 (n = 182)
lin-35; ubc-18(ku354)c,d 4 (n = 192)
lin-35; ubc-18(ku354); efl-1(RNAi)d 57 (n = 95)
a Includes both nonelongated and partially elongated pharynges.
b Experiments were conducted at 16jC.
c Fay et al. (2003).
d Experiments were conducted at 20jC.
e RNAi of these genes caused significant levels of sterility and embryonic
lethality.
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vs. GFP.
pha-1 was initially suggested to encode a transcription
factor of the bZIP family (Granato et al., 1994a). This
assignment was based on relatively weak sequence homol-
ogies between PHA-1 and the leucine-zipper and basic
regions of seven other bZIP family members. However, as
pointed out by the original authors, the spacing of these two
regions in PHA-1 differed substantially from that of known
bZIP proteins. Moreover, our detection of PHA-1::GFP in
the cytoplasm would not be consistent with a role in
transcriptional regulation. We therefore carried out a com-
putational analysis on the predicted PHA-1 peptide to
determine its probable molecular function. Our results
strongly indicate that pha-1 does not encode a bZIP tran-
scription factor. PSORT, as well as several other Internet-
based analysis programs (see Materials and methods), failed
to detect three domains expected to be present in all bZIP
factors including a coiled-coil domain, a leucine zipper, and
a nuclear localization signal. In contrast, of the remaining 18
genes in the C. elegans genome with bZIP annotations, 17
are likely to contain coiled-coil domains (confidence values
z 0.6) based on these analysis tools (data not shown). Other
classes of functional domains were not detected in our
analysis of PHA-1, and the precise molecular function of
this protein remains unclear. Nevertheless, our findings
strongly indicate that pha-1 does not encode a bZIP tran-
scription factor and that its functions reside in the cytoplasm.
Genetic interactions between pha-1 and SynMuv genes
We were interested in determining the degree to which
the genetic interaction between pha-1 and lin-35 might be
interchangeable with other SynMuv genes. Because RNAi
inactivation of lin-35 in the pha-1(e2123) mutant back-
ground (at 16jC) produced a much higher percentage of
Pun larvae than pha-1(fd1) mutants (Table 3), we used the
e2123 allele (at 16jC ) for all interaction tests. In summary,
although the penetrance of the Pun phenotypes differed
between the genes tested (possibly due to differential
responses to RNAi treatment on the individual genes), a
clear synthetic phenotype was observed for all class B
SynMuv genes tested (Table 3). In contrast, the single class
A gene tested, lin-15a, showed no sign of an interaction
(Table 3). The class B genes tested included the histone
deacetylase hda-1 (Lu and Horvitz, 1998); the Mi2 homolog
and NURD complex component let-418 (Solari and
Ahringer, 2000; von Zelewsky et al., 2000); the C. elegans
RbAp46/48 homolog, lin-53 (Lu and Horvitz, 1998); an
E2F homolog, efl-1 (Ceol and Horvitz, 2001); and two
genes of unknown function, lin-36 (Thomas and Horvitz,
1999) and lin-37 (Boxem and van den Heuvel, 2002).
This spectrum of genetic interactions was nearly identical
to that previously observed for ubc-18 (Fay et al., 2003).
However, in contrast to pha-1, we had not previously
detected an interaction between ubc-18 and efl-1. To exam-ine this further, we tested ubc-18 for genetic interactions
with efl-1 using the lin-35; ubc-18 double-mutant strain.
Previous findings indicated that this strain would provide a
more sensitized genetic background than ubc-18(ku354)
single mutants [Fay et al., 2003; also compare the percen-
tages of Pun animals in lin-35; ubc-18(ku354), lin-35; ubc-
18(RNAi), and lin-35; ubc-18(ku354); ubc-18(RNAi) ani-
mals, Tables 1 and 3]. As shown in Table 3, inactivation of
efl-1 by RNAi dramatically increased the percentage of Pun
animals in the lin-35; ubc-18(ku354) double-mutant back-
ground, indicating that, like pha-1, efl-1 also shows genetic
interactions with ubc-18.
PHA-1 and UBC-18 may regulate a common target
Given the striking similarities in their synthetic pheno-
types with lin-35, as well as their matching sets of genetic
interactions with other SynMuv genes, it seemed plausible
that UBC-18 and PHA-1 might function as co-regulators of
a common cellular target. One test of this hypothesis would
be to inactivate both genes simultaneously. If UBC-18 and
PHA-1 share overlapping functions, then a synthetic genetic
interaction would be predicted. Because pha-1 and ubc-18
are located at similar positions on chromosome III (Fay et
al., 2003; Granato et al., 1994a), we inactivated both genes
using combinations of genetic mutations and RNAi (Table
2). In all cases but one, we observed a strong synthetic
genetic interaction between ubc-18 and pha-1, leading to a
Pun phenotype. This included tests in both wild-type and
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alleles of pha-1. The single exception was pha-1(fd1); ubc-
18(RNAi) animals, which probably failed to show an inter-
action because of the weak nature of the fd1 allele and the
incomplete effects of ubc-18(RNAi) (see above and Fay et
al., 2003). We note that because we were limited to the use
of partial LOF mutations for this study, it was not possible
for us to determine whether UBC-18 and PHA-1 work in
tandem or parallel pathways. Nevertheless, these results do
indicate that PHA-1 and UBC-18 are likely to act on a
common target.
As an additional test for functional convergence, we
assayed the ability of two previously isolated extrageneic
suppressors of pha-1 (sup-36 and sup-37) to rescue the
synthetic lethality of lin-35; ubc-18 double mutants (Schna-
bel et al., 1991). sup-36 and sup-37 were previously shown
to suppress the lethal phenotype of multiple strong LOF
alleles in pha-1, indicating that they are very unlikely to be
informational-type suppressors. Strikingly, both mutations
were able to fully suppress the synthetic lethality of lin-35;
ubc-18 double mutants, as well as the lethality observed in
pha-1(e2123); lin-35(RNAi) and in pha-1(e2123); ubc-
18(RNAi) mutants (at 16jC). In contrast, neither mutation
suppressed the expression of the SynMuv phenotype of lin-
35; lin-15a(RNAi) animals, indicating that the suppressors
are specific to the pharyngeal defect and not the lin-35
pathway in general. Taken together, these results strongly
support the model that PHA-1 and UBC-18 function as dual
regulators of a single molecular process.Discussion
A weak loss-of-function mutation in pha-1 reveals an
underlying genetic redundancy
In this report, we have described a synthetic genetic
interaction between LOF mutations in lin-35 and pha-1.
Although both lin-35(n745) and pha-1(fd1) single mutants
are viable and generally appear indistinguishable from wild
type, the large majority of double mutants arrest in early
larval development with variable defects in pharyngeal
development (Fig. 1; Table 1). However, whereas null
mutations in lin-35 show no obvious defects (Lu and
Horvitz, 1998), strong LOF mutations in pha-1 lead to a
highly penetrant embryonic and larval lethality (Granato et
al., 1994a; Schnabel and Schnabel, 1990). Thus, the genetic
redundancy between lin-35 and pha-1 is revealed only
through mutations or treatments (i.e., RNAi) that lead to a
partial reduction in PHA-1 activity.
It is interesting to note that of the two mutations we
have previously reported to show synthetic genetic inter-
actions with lin-35 [fzr-1(ku298) and ubc-18(ku354)], both
resulted in partial LOF mutations in the affected genes (Fay
et al., 2002, 2003). Moreover, in the case of fzr-1, RNAi
injection experiments suggested that a null mutation in fzr-1 may produce a sterile phenotype (Fay et al., 2002).
Therefore, the detection of a genetic interaction between
lin-35 and fzr-1, like pha-1, may have been contingent
upon our ability to isolate partial LOF mutations in this
gene. These findings underscore the versatility and contin-
ued importance of this forward-genetic approach. They also
indicate that functional redundancy is not merely a property
associated with genes that cannot be mutated to an obvious
visible phenotype, such as lin-35. The reality is more likely
that most genes function in a variety of biological process-
es, only some of which can be discerned through the study
of single mutations.
Cell proliferation, differentiation, or morphogenesis?
Several lines of evidence indicate that the morphogenetic
defects observed in lin-35; pha-1 and lin-35; ubc-18 double
mutants are not the direct result of cell cycle perturbations.
One piece of evidence comes from our analyses of pha-1 and
ubc-18 genetic interactions with class B SynMuv genes
(Table 3 and Fay et al., 2003). Namely, both pha-1 and
ubc-18 showed genetic interactions with many class B
SynMuv genes that were previously shown not to play a
role in cell cycle control (Boxem and van den Heuvel, 2002).
At the same time, our current analysis did detect an interac-
tion for both pha-1 and ubc-18with E2F, a protein with well-
characterized cell cycle functions. As discussed in the
Introduction, however, E2F transcriptional targets include
many genes that are not connected to cell cycle control
(Dimova et al., 2003; Ishida et al., 2001; Muller et al., 2001),
and there is precedent for non-cell-cycle functions of E2F in
both Xenopus and C. elegans (Page et al., 2001; Suzuki and
Hemmati-Brivanlou, 2000). In addition, neither cyclin-D nor
cdk4 is required for progression through embryonic cell
cycles in C. elegans (Boxem and van den Heuvel, 2001;
Park and Krause, 1999). Given that these two proteins are the
principal upstream regulators of Rb in cell cycle regulation,
these results indicate that in C. elegans, the Rb pathway is
not controlling embryonic divisions. Finally, the phenotypes
of lin-35; ubc-18 and lin-35; pha-1 double mutants are not
suggestive of defects in cell cycle control (e.g., these mutants
do not undergo supernumerary divisions).
We also obtained strong evidence that terminal differen-
tiation of multiple pharyngeal cell types takes place in both
lin-35; pha-1 and lin-35; ubc-18 double-mutant animals
(this study and Fay et al., 2003). In addition, through our
analysis of the strong LOF mutation, pha-1(e2123), we
found that differentiation of pharyngeal epithelial and mus-
cle cells may occur to a greater extent than earlier reports
had suggested (Figs. 1G, H and data not shown). However,
we note that we did find evidence for a subtle but repro-
ducible delay in the timing of differentiation of pharyngeal
epithelial cells in both lin-35 and pha-1(e2123) (at 25jC)
single mutants (based on the ajm-1::GFP marker; data not
shown). However, given that neither of these single mutants
is defective at early steps of pharyngeal morphogenesis, it is
Fig. 5. Models of functional redundancy. (A) Modified Venn diagram
indicating the hypothesized independent and overlapping targets of LIN-
35, UBC-18, and PHA-1. In the case of LIN-35 and UBC-18, targets are
presumed to be regulated through transcriptional inhibition and ubiquitin-
mediated proteolysis, respectively. The biochemical function of PHA-1 is
not known. Genetic analyses indicate that PHA-1 could act either in a
proteolytic pathway with UBC-18 (indicated by the dashed double-headed
arrow) or through an independent mechanism. Note that the equal size of
the triangles is not meant to suggest that LIN-35, UBC-18, and PHA-1
regulate similar numbers of independent targets. (B, C) Two potential
regulatory circuits to account for the observed genetic interactions of lin-
35, ubc-18, pha-1, sup-36, and sup-37. In panel B, LIN-35, UBC-18, and
PHA-1 converge on a single regulatory target (SUP-37), which if present at
high levels inhibits pharyngeal morphogenesis. In this scenario, SUP-36
functions as an upstream activator of SUP-37 and therefore loss of sup-36
can suppress overexpression of SUP-37. In panel C, LIN-35 and UBC-18 act
on distinct subunits of a molecular complex (SUP-36-SUP-37), whereas
PHA-1 acts on both subunits. In this scenario, loss of LIN-35 and UBC-18
function would result in the moderate overexpression of both subunits.
Given the lethal phenotype of pha-1 strong LOF mutations, PHA-1 is
also shown in both panels to affect pharyngeal development/morpho-
genesis through an independent pathway (dashed line). For additional
details, see text.
D.S. Fay et al. / Developmental Biology 271 (2004) 11–25 23unclear as to how this delay might be relevant to the
observed defects in the double mutants.
Complementary pathways controlling organ morphogenesis
in C. elegans
We have now shown that three genes, lin-35, ubc-18, and
pha-1, function in a partially redundant manner to control
pharyngeal morphogenesis during C. elegans embryonic
development (Tables 1 and 2; Fay et al., 2003). Four pieces
of evidence indicate that the activities of these genes
converge on a common cellular target (or set of targets).
(1) The developmental defects of lin-35; ubc-18 and lin-35;
pha-1 double mutants are essentially indistinguishable. (2)
ubc-18 and pha-1 are identical with respect to their genetic
interactions with SynMuv genes. (3) ubc-18 and pha-1 are
themselves synthetically lethal and display a Pun phenotype
that appears identical to that of lin-35; ubc-18 and lin-35;
pha-1 double mutants (Table 2 and data not shown). (4)
Mutations that can suppress the lethality of strong LOF
mutations in pha-1 also suppress the lethality of lin-35; ubc-
18 double mutants. It is tempting to speculate that these
suppressor mutations may in fact directly affect the mutual
target(s) of LIN-35, UBC-18, and PHA-1 or may occur in
genes that are required for the activation of a common target
(Fig. 5 and also see below).
We have previously suggested a model to explain the
functional redundancy of lin-35 and ubc-18 (Fay et al.,
2003). The model is based on our current understanding
of the principal functions carried out by Rb family
proteins and ubiquitin-conjugating enzymes. Namely,
LIN-35, a presumed negative regulator of transcription,
and UBC-18, a component of the ubiquitin-mediated
proteolysis pathway, would share in common one or more
cellular targets (Fig. 5A). In the absence of either LIN-35
or UBC-18 activity (but not both), sufficient negative
regulation of the mutual target could be brought about
through either pathway acting alone. In the double mutant,
however, two principal means of regulation have now
been abolished, and the activity of the target would go
largely unchecked. More specifically, since both LIN-35
and UBC-18 would be expected to affect the overall
abundance of the target protein (vs. its inherent activity),
the simultaneous loss of both pathways would lead to the
overexpression of the shared target. This model is espe-
cially attractive since we have previously obtained evi-
dence that LIN-35 and FZR-1, a conserved component of
the anaphase-promoting complex (a multisubunit ubiquitin
ligase), cooperate to negatively regulate the levels of G1
cyclins (Fay et al., 2002).
Where PHA-1 may fit into this process is currently
unclear. The initial characterization of pha-1 identified a
weak homology to bZIP transcription factors. However,
based on the expression pattern of a functional PHA-
1::GFP fusion protein (Fig. 4), as well as our computa-
tional analysis of the peptide sequence (see Results), webelieve that this is unlikely to be the case. Moreover,
because PHA-1 does not contain any known motifs to
suggest a biochemical function, we can only speculate at
present as to how PHA-1 may intersect with the LIN-35
and UBC-18 pathways to control pharyngeal morphogen-
esis. Our genetic analysis (Table 2) currently supports a
model whereby PHA-1 could act either in the same
pathway as UBC-18 or through some independent mech-
anism (Fig. 5A).
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tion by LIN-35, UBC-18, (and PHA-1) are the suppressors,
SUP-36 and SUP-37. The rationale is that hypomorphic
mutations in the target would be predicted to compensate
for an overabundance (or hyperactivity) of the protein prod-
uct. Alternatively, suppression could occur if the mutation
affected an important binding partner of the target (e.g., if the
target functions as a heterodimer) or an upstream activator of
the target (Figs. 5B, C). It is also worth pointing out that LIN-
35 and UBC-18 could be acting independently on different
members of a heterodimeric protein complex, such that the
observed synergy results from the simultaneous mis-expres-
sion of both complex subunits (Fig. 5C). As to the molecular
nature of these targets, we can only speculate at present. One
possibility, however, is suggested by a recent paper describ-
ing the role of the ubiquitin ligase, Smurf1, in the regulation
of cell polarity in mammals. Specifically, Smurf1 is recruited
to the leading-edge projections of migrating cells by atypical
protein kinase C and CDC42-PAR6, where it regulates the
actin cytoskeleton through the inhibition of the RhoA
GTPase (Wang et al., 2003). Thus, signaling molecules and
other factors that control cell polarity are obvious candidates
as targets.
Additional studies will be necessary to determine the
function of PHA-1 and to understand how the activities of
PHA-1, LIN-35, and UBC-18 are integrated at the molec-
ular level. These studies will lead to a greater understanding
of Rb family functions in development and will also provide
further insight into the complexities of redundant cellular
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